Eledon Pharmaceuticals Inc (ELDN) Directors and Executive Officers

Officers & Directors

James Robinson
Director

Allan Kirk, M.D.
Director

Walter Ogier
Director

KMJ - Corbin

Paul Little
Chief Financial Officer (Principal Financial and Accounting Officer)

Steven Perrin
President, Director

Hillson, M.D.
Director

John S. McBride
Director

Keith A. Katkin
Chairman of the Board of Directors

David-Alexandre C. Gros, M.D.
Chief Executive Officer and Director (Principal Executive Officer)

Lee, M.D.
Director ,

Eledon Pharmaceuticals Inc currently has 33 employees.

News about Eledon Pharmaceuticals Inc Key Personnel

Eledon Pharmaceuticals Advances Immunosuppressive Therapies with Successful Trial Enrollment and Major Stock Offering

In a significant development within the biotechnology sector, Eledon Pharmaceuticals has made notable strides in its mission to enhance organ transplant outcomes. The company recently announced the successful completion of patient enrollment for its Phase 2 BESTOW clinical trial, aimed at evaluating the efficacy of its lead investigational drug, Tegoprubart, in preventing organ rejection among kidney transplant recipients. This milestone is underscored by the company’s concurrent capital-raising efforts, signaling robust confidence in its innovative approach to transplant medicine.A Closer Look at the BESTOW TrialThe BESTOW trial is a pivotal study designed to address a pressing issue in transplant medicin...